lamivudine has been researched along with Graft vs Host Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biemond, BJ; Jansen, PL; Reesink, HW; Takkenberg, RB; ten Cate, DF; Zaaijer, HL | 1 |
| Boccadoro, M; Bruno, B; Festuccia, M; Fiore, F; Giaccone, L; Marengo, A; Marzano, A; Pittaluga, F; Resta, I; Rizzetto, M; Sorasio, R | 1 |
| Bengu, K; Funda, O; Mehmet, K; Nazan, C; Rasit, Y; Savas, K; Serap, A | 1 |
| Chiba, T; Fukai, K; Imamura, T; Imazeki, F; Kanda, T; Kojima, H; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
1 review(s) available for lamivudine and Graft vs Host Disease
| Article | Year |
|---|---|
[Reactivation of hepatitis B virus in patients with hematological neoplasms].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Female; Graft vs Host Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Male; Risk Factors; Sex Factors; Transplants; Virus Activation | 2009 |
1 trial(s) available for lamivudine and Graft vs Host Disease
| Article | Year |
|---|---|
Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Topics: Adult; Aged; Blood Donors; DNA, Viral; Female; Graft vs Host Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Virus Activation; Young Adult | 2010 |
2 other study(ies) available for lamivudine and Graft vs Host Disease
| Article | Year |
|---|---|
Sustained seroconversion of chronic hepatitis B infection after stem cell transplantation.
Topics: Adaptive Immunity; Adolescent; Graft vs Host Disease; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Immunotherapy; Lamivudine; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Stem Cell Transplantation; Treatment Outcome; Viral Load | 2011 |
Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.
Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; DNA Replication; Female; Graft vs Host Disease; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Middle Aged; Mutation | 2005 |